| Cash Flow | 2025-06-30 |
|---|---|
| Impairment loss | 16,042,422 |
| Fair value of stock options issued to employees | 82,530 |
| Net loss | -22,688,444 |
| Stock compensation issued for services | 668,805 |
| Prepaid expenses and other current assets | 274,633 |
| Other current liabilities | -1,000,000 |
| Leasehold liability | 9,407 |
| Inventory | -7,153 |
| Accrued interest | 114,907 |
| Accrued compensation | 216,480 |
| Deferred revenue | 232,491 |
| Accounts receivable | 67,374 |
| Accounts payable and accrued expenses | -689,107 |
| Loss (gain) from equity method investment | -4,815 |
| Loss from debt extinguishment | -692,270 |
| Gain on settlement | 774,500 |
| Gain on lease termination | 0 |
| Loss from disposal of assets | 0 |
| Loss on disposition | -1,534,517 |
| Stock compensation issued to directors and employees | 0 |
| Depreciation and amortization | 404,198 |
| Amortization of discount on notes payable | 130,908 |
| Non-cash compensation for services | 90,000 |
| Net cash used in operating activities | -5,263,155 |
| Proceeds from sale of fixed assets | 0 |
| Payments to acquire property, plant, and equipment | 23,527 |
| Divesture of naya | 6,569 |
| Net cash used in investing activities | -30,096 |
| Principal payments on notes payable | 1,171,503 |
| Proceeds from warrant exercise | 1,024,637 |
| Proceeds from the sale of notes payable | 0 |
| Proceeds from sale of preferred stock | 500,000 |
| Proceeds from the sale of common stock, net of offering costs | 8,747,902 |
| Preferred stock redemption | 4,000,000 |
| Net cash provided by financing activities | 5,101,036 |
| Increase (decrease) in cash and cash equivalents | -192,215 |
INVO Fertility, Inc. (IVF)
INVO Fertility, Inc. (IVF)